Tianjin Ringpu Bio-Technology Co (SZSE:300119) Long-Term Capital Lease Obligation : ¥6 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co Long-Term Capital Lease Obligation?

Tianjin Ringpu Bio-Technology Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥6 Mil.

Tianjin Ringpu Bio-Technology Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥1 Mil) to Dec. 2024 (¥5 Mil) and increased from Dec. 2024 (¥5 Mil) to Mar. 2025 (¥6 Mil).

Tianjin Ringpu Bio-Technology Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (¥1 Mil) to Dec. 2023 (¥14 Mil) but then declined from Dec. 2023 (¥14 Mil) to Dec. 2024 (¥5 Mil).

Tianjin Ringpu Bio-Technology Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co Long-Term Capital Lease Obligation Chart

Tianjin Ringpu Bio-Technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

56.08

10.60

0.97

14.41

5.25

Tianjin Ringpu Bio-Technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															8.84	4.69	0.72	5.25	5.65

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Tianjin Ringpu Bio-Technology Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Ringpu Bio-Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300

Website

http://www.ringpu.com

Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.

Executives

You Yong Jun	Executives
Xu Lei	Directors, executives
Liang Zhao Ping	Executives
Li Shou Jun	Directors, executives
Bao En Dong	Director
Wang Xing Zhong	Securities Affairs Representative
Peng Yu Peng	Supervisors
Sun Ming	Executives
Liang Wu	Directors, executives
Hu Wen Qiang	Directors, executives
Xu Jian	Securities Affairs Representative
Su Ya La Da Lai	Supervisors
Li Xu Dong	Directors, executives
Dai Jin Ping	Director
Xie Yong	Director

Tianjin Ringpu Bio-Technology Co Headlines

No Headlines